Immunological Activity of Oncolytic Adenovirus Encoding TNF Α and IL-2 (TILT-123) in Combination with Pembrolizumab in Platinum Resistant or Refractory Ovarian Cancer PatientsJames H. Clubb, Matthew S. Block,Johanna Maenpaa,Santeri Pakola,Lyna Haybout,Dafne C. Quixabeira,Tatiana Kudling,Mirte van der Heijden,Elise Jirovec,Tuomo Alanko, Daniel A. Adamo, Susan Ramadan,Jorma Sormunen,Juha Kononen, Julia W. Cohen, Nadena Singh, John Goldfinch,Suvi Sorsa,Riikka Havunen,Claudia Kistler,Joao M. Santos,Victor Cervera-Carrascon,Akseli HemminkiCANCER RESEARCH（2024）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
